Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 11 Billion | USD 18 Billion | 12.2% | 2023 |
The global pharmaceutical quality control market size was evaluated at $11 billion in 2023 and is slated to hit $18 billion by the end of 2032 with a CAGR of nearly 12.2% between 2024 and 2032.
Quality control is a key operation of the pharmaceutical sector. Reportedly, pharmaceutical quality control is also referred to as the obligatory measures required for ensuring the purity as well as quality of a pharmacy product. Moreover, medicines are to be promoted as therapeutically & safe active formulations so that their performance can be predicted accurately. New medicinal agents are produced at a rapid rate and exact & advanced analytical procedures are developed for evaluating them.
Humungous demand for pharmaceutical quality control equipment to embellish the global market surge by 2032
The escalating need for pharmaceutical quality control is anticipated to steer the growth of the global pharmaceutical quality control market. An increase in the price of drug production is predicted to embellish the expansion of the global market. Growing awareness about pharmaceuticals among doctors and patients pertaining to the advantages of making use of pharmaceutical quality control is projected to favorably impact the expansion of the market globally. A surge in the need for developing new analytic tests is anticipated to spearhead the expansion of the market across the globe. Massive highlights on patient safety and the need for drugs free from contamination are likely to embellish the growth of the market globally.
Less availability of expertise can put brakes on the global industry surge over 2024-2032
Technical challenges faced by the workforce while performing various kinds of testing procedures are likely to decimate the growth of the pharmaceutical quality control industry globally. Lack of availability of skilled personnel and fluctuations in the supply chain can create hurdles in the expansion of the industry across the globe.
Rise in the number of medical laboratories across the globe to create new horizons of growth for the global market
Innovations and technological breakthroughs witnessed in the pharmaceutical sector along with constant technological upgrades required for enhancing healthcare quality are projected to generate new growth avenues for the global pharmaceutical quality control market. A surge in accredited clinical labs, a surge in the adoption of third-party quality controls, and a rising inclination towards assistance for external quality assessment are anticipated to shape the expansion of the market globally.
Strict enforcement of legislation by various governments can pose a huge challenge to the global industry surge by 2032
Complicated and time-consuming regulations can pose a huge challenge to the expansion of the global pharmaceutical quality control industry.
The global pharmaceutical quality control market is sectored into product, analysis type, product tested, and region.
In product terms, the pharmaceutical quality control market across the globe is segregated into consumables, services, and instruments segments. Furthermore, the services segment, which accumulated nearly 51% of the global market revenue in 2023, is anticipated to record the highest CAGR over the period from 2024 to 2032. The expansion of the segment from 2024 to 2032 can be due to a rise in the use of pharmaceutical quality control methods in the services segment.
Based on the analysis type, the global pharmaceutical quality control industry is sectored into sterility testing, raw material testing, bioburden testing, extractable & leachable testing, endotoxin testing, and raw material testing segments. Additionally, the sterility testing segment, which amassed a lucrative share of the global industry in 2023, is projected to dominate the segmental elevation in the coming years. The segmental progression from 2024 to 2032 can be attributed to the large-scale use of sterility testing procedures for drugs to ensure patient safety.
Based on the products tested, the global pharmaceutical quality control market is divided into vaccines, drugs, and plasma products segments. Additionally, the vaccines segment, which led the global market expansion in 2023, is anticipated to retain segmental domination during the timeline from 2024 to 2032. The growth of the segment in the coming eight years can be credited to the massive need for vaccine production due to the rapid spread of pandemics such as COVID-19 along with the demand for improving the quality of vaccines.
Report Attributes | Report Details |
---|---|
Report Name | Pharmaceutical Quality Control Market |
Market Size in 2023 | USD 11 Billion |
Market Forecast in 2032 | USD 18 Billion |
Growth Rate | CAGR of 12.2% |
Number of Pages | 216 |
Key Companies Covered | Wixi Apptec, Biomerieux SA, Merck Kgaa, Thermo Fisher Scientific Inc., REMI Group, Perkin Elmer, Shimadzu Scientific Instruments, Esco Micro Pte. Ltd., Charles River Laboratories International Inc., Danaher Corporation, Mettler Toledo, Waters Corporation, Toxikon Corporation, Lucideon Limited, Sartorius AG, BRAM-COR SPA, SGS S.A., and others. |
Segments Covered | By Product, By Analysis Type, By Product Tested, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America is anticipated to retain the dominating position in the global pharmaceutical quality control market in the forecast timeframe
North America, which accounted for nearly 69% of the global pharmaceutical quality control market earnings in 2023, will be a dominating region in the coming seven years. In addition to this, the regional market expansion over the forecast timeframe can be attributed to growing demand from pharma & biotech firms for reducing processing costs through simplification of pharmaceutical quality management systems. In addition to this, the presence of robust healthcare infrastructure in the region and the presence of key manufacturers of molecular quality control components in the sub-continent is predicted to make notable contributions towards the regional market size. Additionally, a shift towards next-gen technologies is anticipated to boost the demand for pharmaceutical quality control in the pharma & biotech sectors of countries such as the U.S. and Canada.
Asia-Pacific pharmaceutical quality control industry is expected to record the fastest CAGR in the forecast timeframe. The expansion of the industry in the APAC region can be owing to the large-scale presence of generic drugs & pharmaceutical manufacturers in the region that also include local as well as multinational firms. Apart from this, the rise in the export of pharmaceutical quality control equipment from countries such as India and China to other countries has contributed immensely to the GDP of these countries, thereby driving the regional industry trends.
The global pharmaceutical quality control market profiles key players such as:
By Product
By Analysis Type
By Product Tested
FrequentlyAsked Questions
Quality control is a key operation of the pharmaceutical sector. Reportedly, pharmaceutical quality control is also referred to as the obligatory measures required for ensuring the purity as well as quality of a pharmacy product.
The global pharmaceutical quality control market growth over forecast period can be owing a surge in the need for developing new analytic tests.
According to a study, the global pharmaceutical quality control industry size was $11 billion in 2023 and is projected to reach $18 billion by the end of 2032.
The global pharmaceutical quality control market is anticipated to record a CAGR of nearly 12.2% from 2024 to 2032.
The Asia-Pacific pharmaceutical quality control industry is set to register the fastest CAGR over the forecasting timeline owing to large-scale presence of generic drugs & pharmaceutical manufacturers in the region that also include local as well as multinational firms. Apart from this, rise in the export of pharmaceutical quality control equipment from countries such as India and China to other countries has contributed immensely to the GDP of these countries, thereby driving the regional industry trends.
The global pharmaceutical quality control market is led by players such as Wixi Apptec, Biomerieux SA, Merck Kgaa, Thermo Fisher Scientific, Inc., REMI Group, Perkin Elmer, Shimadzu Scientific Instruments, Esco Micro Pte. Ltd., Charles River Laboratories International Inc., Danaher Corporation, Mettler Toledo, Waters Corporation, Toxikon Corporation, Lucideon Limited, Sartorius AG, BRAM-COR SPA, and SGS S.A.
The global pharmaceutical quality control market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed